NASDAQ: ARDXArdelyx Inc Stock Ownership - Who owns Ardelyx?
Insider buying vs selling
Have Ardelyx Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Raab | President CEO | 2025-04-04 | 41,666 | $4.59 | $191.16kSell |
| Michael Raab | President CEO | 2025-04-04 | 20,833 | $0.99 | $20.62kBuy |
| Michael Raab | President CEO | 2025-03-07 | 41,668 | $5.36 | $223.22kSell |
| Michael Raab | President CEO | 2025-03-07 | 20,834 | $0.99 | $20.63kBuy |
| David M. Mott | Director | 2025-02-24 | 77,729 | $5.00 | $388.72kBuy |
| Justin A. Renz | Chief Financial Officer | 2025-02-20 | 5,171 | $5.62 | $29.08kSell |
| Elizabeth A. Grammer | Chief Legal and Administrative Officer | 2025-02-20 | 4,291 | $5.62 | $24.13kSell |
| Laura A. Williams | Chief Medical Officer | 2025-02-20 | 4,941 | $5.62 | $27.78kSell |
| Michael Raab | President CEO | 2025-02-20 | 22,964 | $5.62 | $129.13kSell |
| Michael Raab | President CEO | 2025-01-31 | 41,666 | $5.36 | $223.37kSell |
ARDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ARDX insiders and whales buy or sell their stock.
ARDX Shareholders
What type of owners hold Ardelyx Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Janus Henderson Group PLC | 10.23% | 24,387,941 | $130.48M | Institution |
| Krishna Kittu Kolluri | 9.05% | 21,572,475 | $115.41M | Insider |
| Peter J. Barris | 7.89% | 18,800,125 | $100.58M | Insider |
| Blackrock Inc | 7.77% | 18,521,477 | $99.09M | Institution |
| M. James Barrett | 7.52% | 17,921,753 | $95.88M | Insider |
| Patrick J. Kerins | 7.41% | 17,666,935 | $94.52M | Insider |
| Forest Baskett | 6.84% | 16,299,721 | $87.20M | Insider |
| Vanguard Group Inc | 6.03% | 14,362,659 | $76.84M | Institution |
| Scott D. Sandell | 5.75% | 13,709,147 | $73.34M | Insider |
| Nea Partners 12 Limited Partnership | 5.75% | 13,706,135 | $73.33M | Insider |
ARDX vs Biotech Stocks
Ardelyx Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.